The precise and reliable measurement of GFR has Background. The aim of the present study was to been studied and debated ever since it was introduced compare the most commonly used GFR markers for more than 70 years ago using creatinine as a marker clearance measurements, 51Cr-EDTA and iohexol, [1]. Inulin was subsequently introduced by Shannon using two different methods for iohexol analysis, HPLC and Smith [2] in the 30s, and inulin is still used as the and X-ray fluorescence, referring both to the multiple-major reference substance for GFR measurements. sample and single-sample calculations, using 51Cr-However, inulin is expensive and tedious to use. In EDTA as the reference method. recent years, two major classes of substance have been Methods. Forty-nine patients with an estimated GFR introduced as alternatives to inulin for the measure->40 ml/min were included. 51Cr-EDTA and iohexol ment of GFR, namely the cheleating agents EDTA were injected simultaneously and blood samples were and DTPA, and the radiological contrast media such taken 150, 195 and 240 min after injection of the as iothalamate, diatrizoate, and most recently iohexol respective marker.
Introduction
ance method, i.e. calculations of the clearance value based on the plasma disappearance rate of the indicator In clinical practice, measurement of the glomerular after a single injection. filtration rate, GFR, is the major kidney function test.
The aim of this investigation was to make a comparison of iohexol, assessed with two completely different catheters, the injection of GFR marker was given, followed by at least 30 ml of saline, and later the samples were taken from the catheter in the contralateral arm, as well as from
Subjects and methods
the 'injection' arm. Plasma, obtained from both venous catheters was analysed separately and GFR calculated. No Patients differences in GFR values could be observed. It must be stressed, however, that it is of great importance that the Fifty consecutive patients, referred to the Department of venous catheter is flushed with at least 30 ml of saline Clinical Physiology at the Sahlgrenska University Hospital following injection, thereby avoiding 'contamination' of 51Cr-for routine GFR measurement, were asked to volunteer, EDTA or iohexol. according to a protocol approved by the ethical committee.
Twenty-five males, age range 19-74 years (mean age 48 Clearance determinations (see Appendix) years) and 25 females, age range 19-82 years (mean age 53 years), agreed to participate.
All clearances were calculated according to commonly used All patients had an estimated GFR >40 ml/min/1.73 m2 methods. Plasma clearance was calculated according to BSA, as determined using creatinine, age, weight and gender with the modification that the of the patients [11] . The patients suffered from different plasma disappearance curve was determined by three measrenal diseases as shown in Table 1 . They were all in stable urements, 150, 195 and 240 min after injection. Plasma conditions at the time of the investigation. Due to technical clearance was also calculated using the single-sample cleardifficulties one patient was excluded from the calculations.
ance according to the Jacobsson formula [13] .
Study protocol Analysis techniques
The investigation started at 8 a.m. and the patients were The radioactivity of 51Cr-EDTA in the plasma samples was allowed a light breakfast but were asked to refrain from measured together with a standard (3 ml ) in a gamma smoking. An indwelling venous Teflon catheter was inserted counter (15 min for each sample). The standard was prepared into an antecubital vein. A blood sample of 10 ml was from the same solution that was given to the patient. An obtained for background measurements. The markers were exact amount of the 51Cr-EDTA solution was weighed carethen given as single-injections. First 51Cr-EDTA was injected fully and added to 250 ml distilled water. (3.7 MBq, Amersham, UK ) and then, after having rinsed Iohexol was measured with two different techniques, the the cannula using 30 ml saline, 20 ml of iohexol (Omnipaque X-ray fluorescence technique and HPLC. For measuring the 300 mgl/ml, Nycomed, Norway) was given within the next X-ray fluorescence the Renalyzer apparatus (PRX 90, minute and the cannula was again flushed with saline. The Provalid, Sweden) was used. The plasma samples were exact time for the injection was registered and the syringes inserted into the Renalyzer for a measuring time of 5 min used for the 51Cr-EDTA and iohexol injections were carefully and exposed to the radiation of 60 keV photons emitted weighed before and after the injections.
from two sources of 241Am (11 GBq). The iodine in the Blood samples for analyses were then obtained, starting iohexol molecules then emitts characteristic X-rays which are 2.5 h after the injections of the GFR markers. To define the registered by a 6-channel analyser. The X-ray radiation is plasma disappearance curve of the GFR markers, three proportional to the concentration of iohexol in the plasma blood samples (10 ml each) were obtained at 150, 195 and samples. Repeated analyses of iohexol (iodine concentration 240 min after the injections. After centrifugation (3000 g for range 30.7-245.3 mg/l ), measured by X-ray fluorescence 10 min), 3 ml plasma was used for scintillation counting of technique, were made for methodological testing, and yielded 51Cr-EDTA, 200 m1 for HPLC measurements, and 3 ml for a coefficent of variation of 3%. The precision and accuracy the X-ray fluorescence analysis.
of the X-ray fluorescence analysis of iodine for concentrations During the waiting time between the start of the measure-below 60 mg/l were less than those for the HPLC. Hence, ment and the first blood sample after 2.5 h, the patients were it is important that the injected dose of iohexol is at least allowed to move around freely and also to have a light meal, 20 ml, preventing concentration from being too close to the but they were still asked to refrain from smoking. The blood lower level of detection (Table 2) . samples were all taken from the same venous catheter in Iohexol was also determined by the HPLC [14, 15] . In which the injection had been given.
brief, plasma samples were deproteinized by adding equal volume of 0.6 M perchloric acid to a 200-ml sample. Twenty- Six mixtures were prepared individually for each level of concentration by a series dilution of iohexol stock standard, which in turn was prepared from a newly opened OmnipaqueA vial (300 mg/ml ).
was based on assessment of peak area. The method was validated within a concentration range from 3.8-529.0 mg/l. An excellent linearity was obtained. The detection limit for a signal to noise ratio of a factor 3 was 1.2 mg/l. Interassay coefficient of variation for iohexol in plasma control samples on two concentration levels, 44 and 106 mg/l, was 2.8 and 3.2% respectively.
Results
There were 49 complete sets of clearance measurements available for comparison. Each set consisted of GFR measured with the two GFR markers, 51Cr-EDTA and iohexol, both with the multiple-sample and the singlesample clearance for each marker.
In Figure 1 the data are presented for iohexol multiple-sample clearance estimation performed by HPLC and X-ray fluorescence. In both cases a statistically significant correlation was obtained. The slopes and the intercepts were not different from 1 and zero respectively, on the 5% significance level, indicating that both methods give GFR results equivalent to 51Cr-EDTA measurements.
Linear regression analysis was performed in order to compare the GFR results obtained from measurements with the two markers using the three-sample method and single-sample method. The multiplesample method with 51Cr-EDTA was considered as a reference method for GFR measurement, to which one-sample 51Cr-EDTA clearance, one-sample iohexol The slope parameter for one-sample clearance estimation with 51Cr-EDTA and HPLC with iohexol was 0.97 and 0.96 respectively, and it was not statisticIn Figure 3 the difference between 51Cr-EDTA, as reference method, and multiple-point clearance measally different from 1 (5% significance level ). The slope for one-sample iohexol clearance by X-ray fluorescence ured by HPLC and X-ray fluorescence, are plotted against the mean value of the compared methods. The (0.83) was statistically different from the line of identity. The intercept differed from origo in the case of points are evenly distributed around the zero line over the whole clearance range. The calculated mean differiohexol clearance measured by X-ray fluorescence, while for the HPLC and 51Cr-EDTA methods, the ence, their standard deviation, and clearance range for all methods are presented in Table 3 . intercepts were not different from zero. Fig. 3 . Relationship between the difference of multiple-point clearance of 51Cr-EDTA as reference method and the multiple-point clearance meaurements of iohexol by HPLC and iohexol by X-ray fluorescence and their mean clearance distribution. Upper. Difference between 51Cr-EDTA 3 samples and iohexol 3 samples clearance by HPLC against the mean clearance distribution of 51Cr-EDTA 3 samples and iohexol 3 samples. Lower. Difference between 51Cr-EDTA 3 samples and iohexol 3 samples clearance by X-ray fluorescence against the mean clearance distribution of 51Cr-EDTA and iohexol 3 samples by X-ray fluorescence measurements. Table 3 . Clearance range, mean of differences and standard deviation for multiple-point clearance and single-point clearance measurements Clearance Difference range (ml/min) (ml/min) Mean SD Fig. 2 . Comparison of GFR measured by two different clearance Multiple-point clearance: 3 samples 51Cr-EDTA vs 3 samples iohexol methods. 51Cr-EDTA and iohexol, using the single plasma sample 51Cr-EDTA vs HPLC 28-134 −0.16 6.17 method in 49 patients using 51Cr-EDTA multiple-point clearance as 51Cr-EDTA vs X-ray fluorescence 29-134 0.58 4.95 reference. Iohexol measured with two different techniques, HPLC Single-point clearance: 3 samples 51Cr-EDTA vs 1 sample and X-ray fluorescence. Upper. Plasma clearance; 51Cr-EDTA 3 51Cr-EDTA vs 51Cr-EDTA 26-123 −0.7 3.59 samples vs 51Cr-EDTA 1 sample. Middle. Plasma clearance; 51Cr-51Cr-EDTA vs HPLC 27-125 −1.7 5.94 EDTA 3 samples vs iohexol 1 sample by HPLC. Lower. Plasma 51Cr-EDTA vs X-ray fluorescence 32-116 −1.32 5.78 clearance; 51CrEDTA 3 samples vs iohexol 1 sample by X-ray fluorescence.
In Figure 4 the corresponding data of differences analysis, indicating a difference between these two methods. The GFR below 75 ml/min tends to be for single-sample clearance are presented. The distribution of data around the zero identity line for one overestimated, whereas the GFR above 75 ml/min is underestimated, when using the X-ray fluorescence sample iohexol clearance measured with X-ray fluorescence technique, substantiates the results of regression method for single-sample GFR measurement.
Discussion
In this study we have compared GFR measurements using the recently introduced GFR marker iohexol with the well-known and reliable marker 51Cr-EDTA. We have shown that over the wide GFR range of 40-130 ml/min, iohexol clearance measurements correlated closely to those of 51Cr-EDTA. Furthermore, there was no difference between the clearance measurement irrespective of whether iohexol was analysed by means of the HPLC method or the fluorescence technique.
Non-radioactive contrast agents have come to play a more important role for determining GFR. Not only can GFR be determined in combination with a routine X-ray, using doses of 50-100 ml of e.g. iohexol [16 ] but the iohexol can also be used in a low dose, specifically aimed at assessing GFR [17, 18] . Sensitive assay techniques have also evolved, such as the Renalyzer, utilizing X-ray fluorescence of iodine and the development of HPLC for measuring iohexol concentration [5, 17, 18] . Corroborating with the data of the present study, others have also found a good correlation with plasma clearance of iohexol, not only when compared to inulin but also to that of 51Cr-EDTA and 99mTc-DTPA [5, 7, 17, [19] [20] [21] [22] [23] . Furthermore, Brown and O'Reilly [7] made a detailed study utilizing bladder catheterization and the classical continuous infusion technique, and showed an excellent correlation between the renal clearances of iohexol and inulin.
In patients with severe impairment of renal function, contrast media are known to be nephrotoxic, especially in diabetic patients. However, slow intravenous injection of a small dose of contrast medium in a clearance procedure, as in the present study, is not nephrotoxic as is the case for a high-pressure injection, using several times more substance in an X-ray examination. Thus, one may preferentially use a low dose (<20 ml ) of iohexol (300 mg I/ml ). For example, in a large study of approximately 4000 iohexol clearance measurements, using a low dose of iohexol, no severe adverse reaction was noted [24] . Other adverse reactions such as allergic, hypotensive, and dyspeptic reactions are very rare as well, when iohexol is used for clearance measurements [25] . This is certainly due to the mode of administration and the low dose used.
Iodine could be measured not only by the sensitive Fig. 4 . Relationship between the difference of multiple-point clear-HPLC method but also by using the Renalyzer techance of 51Cr-EDTA as reference method and single-point clearance nique (Provalid, Lund, Sweden), which is based on of 51Cr-EDTA, iohexol by HPLC and iohexol by X-ray fluorescence X-ray fluorescence. This is a simple and sensitive and their mean clearance distribution. Upper. Difference between 51Cr-EDTA 3 samples and 51Cr-EDTA 1 sample clearance against technique, provided that the iodine concentration the mean clearance distribution of 51Cr-EDTA 3 samples and 51Cr-exceeds approximately 0.06 mg iodine per ml. The tech-EDTA 1 sample measurements. Middle. Difference between 51Cr-nique is reported to yield a sufficiently linear relation-EDTA 3 samples and iohexol 1 sample clearance by HPLC against ship in the region of clinical interest, including the mean clearance distribution of 51Cr-EDTA 3 samples and iohexol 1 sample by HPLC. Lower. Difference between 51Cr-EDTA 3 samples concentrations in the range of 0.05 mg iodine per ml and iohexol 1 sample clearance by X-ray fluorescence against the to 7 mg iodine per ml. Thus care has to be taken when mean clearance distribution of 51Cr-EDTA 3 samples and iohexol 1 iodine concentrations tend to be low, as in high clearsample by X-ray fluorescence.
ance intervals, the variation of the results between repeated analysis of the same sample is about ±4% in the interval of 0.1-4 mg iodine per ml [9] . When low
